CClinicalTrials.gg
CompletedNCT05640856Updated Dec 7, 2022

Relationship Between STOP BANG Score and Airway Management

An observational study in Airway Obstruction, Obstructive Sleep Apnea and Hypoxia, sponsored by Zonguldak Bulent Ecevit University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-07.

Sponsored by Zonguldak Bulent Ecevit University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Nowadays, anesthetists may encounter many patients who are not diagnosed with obstructive sleep apnea syndrome (OSAS) to undergo elective surgery. Recognition of these patients by anesthesiologists and taking necessary precautions will significantly reduce perioperative complications and mortality. STOP-BANG is a questionnaire used to predict high risk of OSAS. The aim of our study is to evaluate the clinical use of the oxygen reserve index as an early warning of possible desaturation in patients with low and high risk of OSAS according to the Stop Bang score.

02

Conditions studied

  • Airway Obstruction
  • Obstructive Sleep Apnea
  • Hypoxia

Keywords

  • Oxygen Reserve Index
  • STOP BANG Score
  • Difficult Airway
03

In context

Sleep Apnea, Obstructive

2,198 studies on the registry are indexed under Sleep Apnea, Obstructive; 469 are open to participants now.

This study's enrollment of 1 is below the median of 104 across 648 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Zonguldak Bulent Ecevit University is the lead sponsor of 96 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients aged 18-65 to be intubated undergoing elective surgery

Inclusion criteria

  • American Society of Anesthesiologists (ASA) I-III
  • Between 18-65 years old
  • Volunteered to participate in the study

Exclusion criteria

Exclusion Criteria:

  • diagnosed with asthma, COPD, heart failure or coronary artery disease, OSAS
  • morbidly obese (BMI>45 kg/m2),
  • patients with a history of alcohol or drug addiction
  • women in pregnancy or lactation
  • allergic to the drugs used in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1 participant (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Group D

    STOP BANG Score \<3

    Procedure: intubation

  • Group Y

    STOP BANG Score ≥ 3

    Procedure: intubation

Interventions

  • Procedureintubation

    Endotracheal tube placement

06

What researchers measure

Primary outcomes

  1. Evaluation of Oxygenation

    prediction of desaturation by oxygen reserve index in patients with low and high risk of OSAS

    Time frame: up to intubation

Secondary outcomes

  1. Evaluation of difficult Airway

    using mask-ventilation scale in patients with low and high risk of OSAS

    Time frame: up to intubation

07

Study locations

1 site
  • Zonguldak Bülent Ecevit University Medicine Faculty
    Zonguldak, Kozlu 67600, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05640856
Lead sponsor
Zonguldak Bulent Ecevit University
Responsible party
Bengü Gülhan Köksal (Principal Investigator, Zonguldak Bulent Ecevit University) — Principal investigator
First posted
Dec 7, 2022
Start date
Jan 1, 2021
Primary completion
Jun 30, 2022
Completion
Nov 1, 2022
Last update
Dec 7, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion